Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 51407-184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 51407-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51407 184 05lb

51407 184 05lb
This is a description of a medication product manufactured by GSMS Incorporated. The product mentioned is a delayed-release tablet called Rabeprazole that contains 20mg of rabeprazole sodium, and is available in a pack of 500 tablets. The package insert provides dosage information, and the product must be stored at a temperature between 15°C-30°C (59°F-86°F) with excursions (brief storage at temporary temperatures) permitted. The medication needs to be protected from moisture and dispensed in tight containers. A medication guide needs to be provided with each patient, and the product must be kept out of reach of children. The product is packaged by GSMS Incorporated located in Camarillo, CA, but manufactured by Lannett Company Inc. located in Seymour, IN.*
FDA Label Image

Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)

Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)
FDA Label Image

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)
This text presents data from a study evaluating the efficacy of a drug called RAB, at two different doses (10mg and 20mg), compared to a placebo, in a sample of 68 individuals. The data is presented over a period of 21 days, with heartburn scores ranging from zero (no heartburn) to four (very severe heartburn).*
FDA Label Image

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)
This appears to be a tabular format with data on two drugs - Placebo and RAB in two different dosages (10mg and 20mg). The number of participants receiving each of these treatments is also provided.*
FDA Label Image

Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)

Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)
FDA Label Image

Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)

Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.